Is fluorescein-guided technique able to help in resection of high-grade gliomas?

Neurosurgical Focus

Volumn 36, Issue 2, 2014, Pages

  Acerbi, Francesco ^a   Broggi, Morgan ^a   Eoli, Marica ^a   Anghileri, Elena ^a   Cavallo, Claudio ^a   Boffano, Carlo ^a   Cordella, Roberto ^a   Cuppini, Lucia ^a   Pollo, Bianca ^a   Schiariti, Marco ^a   Visintini, Sergio ^a   Orsi, Chiara ^b   La Corte, Emanuele ^a   Broggi, Giovanni ^a   Ferroli, Paolo ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Fluorescein; Malignant gliomas; Total removal; YELLOW 560

Indexed keywords

DIAGNOSTIC AGENT; FLUORESCEIN; FLUORESCENT DYE;

AGED; ARTICLE; BRAIN TUMOR; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MALE; METHODOLOGY; MICROSURGERY; MIDDLE AGED; MORTALITY; NEURONAVIGATION; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; SURVIVAL RATE;

AGED; BRAIN NEOPLASMS; FEMALE; FLUORESCEIN; FLUORESCENT DYES; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; MICROSURGERY; MIDDLE AGED; NEURONAVIGATION; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84894283745     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2013.11.FOCUS13487     Document Type: Article

References (33)

1. Acerbi F, Broggi M, Eoli M, Anghileri E, Cuppini L, Pollo B, et al: Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases. Acta Neurochir (Wien) 155:1277-1286, 2013.
2. Cordella R, Acerbi F, Broggi M, Vailati D, Nazzi V, Schiariti M, et al: Intraoperative neurophysiological monitoring of the cortico-spinal tract in image-guided mini-invasive neurosurgery. Clin Neurophysiol 124:1244-1254, 2013.
3. Dilek O, Ihsan A, Tulay H: Anaphylactic reaction after fluorescein sodium administration during intracranial surgery. J Clin Neurosci 18:430-431, 2011.
4. Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, et al: Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin Cancer Res 13:2606-2613, 2007.
5. Koc K, Anik I, Cabuk B, Ceylan S: Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br J Neurosurg 22:99-103, 2008.
6. Kubben PL, ter Meulen KJ, Schijns OE, ter Laak-Poort MP, van Overbeeke JJ, van Santbrink H: Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol 12:1062-1070, 2011.
7. Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C: Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13:1339-1348, 2011.
8. Kuroiwa T, Kajimoto Y, Ohta T: Development of a fluorescein operative microscope for use during malignant glioma surgery: a technical note and preliminary report. Surg Neurol 50:41-49, 1998.
9. Kwan AS, Barry C, McAllister IL, Constable I: Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Experiment Ophthalmol 34:33-38, 2006.
10. Kwiterovich KA, Maguire MG, Murphy RP, Schachat AP, Bressler NM, Bressler SB, et al: Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology 98:1139-1142, 1991.
11. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001.
12. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: WHO Classification of Tumours of the Central Nervous System. Lyon: IARC Press, 2007.
13. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156-162, 2009.
14. Moore GE, Peyton WT, French LA, Walker WW: The clinical use of fluorescein in neurosurgery. The localization of brain tumors. J Neurosurg 5:392-398, 1948.
15. Nimsky C, Ganslandt O, Buchfelder M, Fahlbusch R: Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI. Neurol Res 28:482-487, 2006.
16. Novotny HR, Alvis DL: A method of photographing fluorescence in circulating blood in the human retina. Circulation 24:82-86, 1961.
17. Pollo B: Neuropathological diagnosis of brain tumours. Neurol Sci 32 (Suppl 2):S209-S211, 2011.
18. Schebesch KM, Proescholdt M, Höhne J, Hohenberger C, Hansen E, Riemenschneider MJ, et al: Sodium fluorescein-guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery-a feasibility study. Acta Neurochir (Wien) 155:693-699, 2013.
19. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V: Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12:997- 1003, 2011.
20. Shinoda J, Yano H, Yoshimura S, Okumura A, Kaku Y, Iwama T, et al: Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg 99:597-603, 2003.
21. Stummer W, Meinel T, Ewelt C, Martus P, Jakobs O, Felsberg J, et al: Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery. J Neurooncol 108:89-97, 2012.
22. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003- 1013, 2000.
23. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006.
24. Stummer W, Stocker S, Novotny A, Heimann A, Sauer O, Kempski O, et al: In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 45:160-169, 1998.
25. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, et al: Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42:518-526, 1998.
26. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459- 466, 2009.
27. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005.
28. Tanahashi S, Lida H, Dohi S: An anaphylactoid reaction after administration of fluorescein sodium during neurosurgery. Anesth Analg 103:503-504, 2006 (Letter).
29. Tonn JC, Stummer W: Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. Clin Neurosurg 55:20-26, 2008.
30. Unsgaard G, Ommedal S, Muller T, Gronningsaeter A, Nagelhus Hernes TA: Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection. Neurosurgery 50:804-812, 2002.
31. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al: Updated response assessment criteria for high-grade gliomas: response assessment in neurooncology working group. J Clin Oncol 28:1963-1972, 2010.
32. Wirtz CR, Albert FK, Schwaderer M, Heuer C, Staubert A, Tronnier VM, et al: The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery. Neurol Res 22:354-360, 2000.
33. Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, et al: Fluorescein angiography complication survey. Ophthalmology 93:611-617, 1986.